US Patent 10526398 Anti-dengue virus antibodies and applications thereof
Patent 10526398 was granted and assigned to National Defense Medical Center on January, 2020 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10526398 Anti-dengue virus antibodies and applications thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.